METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE
Star0
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE
- DrugBank Accession Number
- DB07765
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 450.4936
Monoisotopic: 450.212786738 - Chemical Formula
- C22H26N8O3
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UPutative dehydrogenase/reductase SDR family member 4-like 2 Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as 1-benzoylpiperidines. These are compounds containing a piperidine ring substituted at the 1-position with a benzoyl group.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Benzoyl derivatives
- Direct Parent
- 1-benzoylpiperidines
- Alternative Parents
- N-benzoylpiperidines / Pteridines and derivatives / Aminobenzamides / Piperidinecarboxylic acids / Benzamides / Aniline and substituted anilines / Dialkylarylamines / Aminopyrimidines and derivatives / Aralkylamines / Pyrazines show 12 more
- Substituents
- 1-benzoylpiperidine / Amine / Amino acid or derivatives / Aminobenzamide / Aminobenzoic acid or derivatives / Aminopyrimidine / Aniline or substituted anilines / Aralkylamine / Aromatic heteropolycyclic compound / Azacycle show 30 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- UKCFUFHREWUXJJ-UHFFFAOYSA-N
- InChI
- InChI=1S/C22H26N8O3/c1-29(12-15-11-25-19-17(26-15)18(23)27-22(24)28-19)16-5-3-13(4-6-16)20(31)30-9-7-14(8-10-30)21(32)33-2/h3-6,11,14H,7-10,12H2,1-2H3,(H4,23,24,25,27,28)
- IUPAC Name
- methyl 1-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)piperidine-4-carboxylate
- SMILES
- COC(=O)C1CCN(CC1)C(=O)C1=CC=C(C=C1)N(C)CC1=NC2=C(N)N=C(N)N=C2N=C1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 23629645
- PubChem Substance
- 99444236
- ChemSpider
- 21376082
- BindingDB
- 50398394
- ChEMBL
- CHEMBL1232702
- ZINC
- ZINC000053683191
- PDBe Ligand
- FE1
- PDB Entries
- 2qhx / 6rx5
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.242 mg/mL ALOGPS logP 1.63 ALOGPS logP 0.75 Chemaxon logS -3.3 ALOGPS pKa (Strongest Acidic) 15.87 Chemaxon pKa (Strongest Basic) 1.82 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 9 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 153.45 Å2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 125.89 m3·mol-1 Chemaxon Polarizability 47.89 Å3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9807 Blood Brain Barrier + 0.7827 Caco-2 permeable - 0.7154 P-glycoprotein substrate Substrate 0.7924 P-glycoprotein inhibitor I Inhibitor 0.6371 P-glycoprotein inhibitor II Non-inhibitor 0.5478 Renal organic cation transporter Non-inhibitor 0.6772 CYP450 2C9 substrate Non-substrate 0.9139 CYP450 2D6 substrate Non-substrate 0.8033 CYP450 3A4 substrate Substrate 0.5612 CYP450 1A2 substrate Non-inhibitor 0.8328 CYP450 2C9 inhibitor Non-inhibitor 0.6364 CYP450 2D6 inhibitor Non-inhibitor 0.8695 CYP450 2C19 inhibitor Non-inhibitor 0.6771 CYP450 3A4 inhibitor Non-inhibitor 0.9179 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.7001 Ames test Non AMES toxic 0.6824 Carcinogenicity Non-carcinogens 0.9228 Biodegradation Not ready biodegradable 0.9528 Rat acute toxicity 2.6025 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.8706 hERG inhibition (predictor II) Inhibitor 0.7693
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0a4i-0009400000-33efa2629d3fec9f66e1 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0002-0000900000-a8bfca6af2eefa2ac3ab Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0005-0114900000-237d205ec4bd478face0 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0pb9-0309300000-0e1ba94ab5368a9fc36f Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-004i-0914200000-199b9e783eba02eb4fe3 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-053f-0309600000-881e7cb7a43112fbe348 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 203.22295 predictedDeepCCS 1.0 (2019) [M+H]+ 205.61852 predictedDeepCCS 1.0 (2019) [M+Na]+ 211.53105 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Oxidoreductase activity
- Specific Function
- Putative oxidoreductase.
- Gene Name
- DHRS4L1
- Uniprot ID
- P0CG22
- Uniprot Name
- Putative dehydrogenase/reductase SDR family member 4-like 1
- Molecular Weight
- 30607.35 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:25 / Updated at June 12, 2020 16:52